Next Generation Imaging Using Serial 18F-flutemetamol PET to Assess Diagnostic Performance and/or Disease Stabilization in Patients with Transthyretin Amyloid Cardiomyopathy Treated with Tafamidis Sponsor Deadline: Feb 1, 2021 Sponsor: GE Healthcare and Pfizer Inc. (deadline extended to 2/1/2021)UI Contact: mary-blackwood@uiowa.edu Updated Date: Oct 8, 2020 Email this